Table 2.
Variables | Patient Number (%) | Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|---|---|
Death n = 56 | Survival n = 885 | Odds Ratio (95% CI) | p Value | Odds Ratio (95%CI) | p Value | |
Gender, male | 37 (66.1) | 359 (40.6) | 2.85 (1.62–5.04) | <0.001 | NS | NS |
Pitt bacteremia score | ||||||
≥4 at onset | 30 (53.6) | 117 (13.2) | 7.57 (4.33–13.26) | <0.001 | 2.59 (1.34–5.03) | 0.005 |
=0 ay day 3 | 11 (19.6) | 690 (78.0) | 0.07 (0.04–0.14) | <0.001 | 0.21 (0.11–0.41) | <0.001 |
Ultimately and rapidly fatal comorbidities (McCabe classification) | 31 (55.4) | 165 (18.6) | 5.41 (3.11–9.41) | <0.001 | 3.20 (1.62–6.33) | 0.001 |
Comorbidities | ||||||
Malignancies | 30 (53.6) | 221 (25.0) | 3.47 (2.01–5.99) | <0.001 | 1.98 (1.02–3.86) | 0.04 |
Hypertension | 18 (32.1) | 444 (50.2) | 0.47 (0.26–0.84) | 0.009 | NS | NS |
Liver cirrhosis | 18 (32.1) | 108 (12.2) | 3.41 (1.88–6.18) | <0.001 | 2.15 (1.08–4.27) | 0.03 |
Sources of bacteremia | ||||||
Pneumonia | 22 (39.3) | 69 (7.8) | 7.65 (4.24–13.80) | <0.001 | 3.19 (1.64–6.23) | 0.001 |
Urinary tract infections | 10 (17.9) | 466 (52.7) | 0.20 (0.10–0.39) | <0.001 | 0.32 (0.16–0.52) | 0.001 |
NS = No significance (after processing the stepwise and backward multivariate regression).